Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-05-10 @ 11:40 AM
Study NCT ID:
NCT02981303
Status:
COMPLETED
Last Update Posted:
2024-07-09
First Post:
2016-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
Sponsor:
HiberCell, Inc.
Organization: